Neoantigens Market Outlook at US$ 5,607.32 Million by 2034
Neoantigens are uniquely altered protein fragments generated by non-synonymous mutations within tumor genomes. These novel antigens are processed intracellularly and displayed on the cell surface, where they can be detected by the adaptive immune system as foreign entities. Their high tumor specificity and variability between patients make them fundamental to individualized cancer vaccine...
0 Σχόλια 0 Μοιράστηκε 48 Views 0 Προεπισκόπηση